Shanghai, China

Liuxin Xu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: East China University of Science and Technology. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liuxin Xu. Retrieved from https://idiyas.com/inventor/liuxin-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liuxin Xu: Innovator in Pharmaceutical Chemistry

Introduction

Liuxin Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. His work is characterized by a focus on innovative solutions for treating diseases.

Latest Patents

Liuxin Xu holds a patent for a thiazole derivative, which serves as a DHODH inhibitor. This invention specifically relates to a compound represented by formula I, along with a pharmaceutical composition containing this compound. The applications of this compound are aimed at preparing drugs for treating diseases mediated by DHODH or for inhibiting DHODH activity. He has 1 patent to his name.

Career Highlights

Liuxin Xu is affiliated with the East China University of Science and Technology, where he engages in research and development activities. His academic background and research focus have positioned him as a key figure in his field.

Collaborations

Liuxin Xu collaborates with notable colleagues, including Jing Liu and Honglin Li. Their combined expertise enhances the research output and innovation within their projects.

Conclusion

Liuxin Xu's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…